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Background: In 2010, we observed children with atypical presentations of hand-foot-mouth disease (HFMD), such
as rashes on earlobes and faces, or bullae on trunks and bilateral limbs. Hyperpigmentation later developed as the
bullous lesions crusted. Thus, we intended to study the etiology of the illness and the phylogeny of the pathogens.
Method: Patients were prospectively enrolled in a tertiary medical center in Taipei, Taiwan. The definition of atypical
HFMD includes symptoms of acute viral infection with either of the following presentations: (1) maculopapular rashes
presenting on the trunks, buttocks or facial areas, or (2) large vesicles or bullae on any sites of the body. Patients were
classified into two groups according to vesicle sizes by two pediatricians at different points in time. The large vesicle
group was defined as having vesciculobullous lesions ≥ 1 cm in diameter; the small rashes group had maculopapular
rashes < 1cm in diameter. Two throat swabs were collected from each patient for virus isolation and reverse
transcription polymerase chain reactions.
Results: We enrolled 101 patients between March and December 2010. The mean age of the participants was 3.3 ±
3.0 years (median age: 2.5 years, range: 21 days-13.5 years). The ratio of males to females was 1.8 to 1. All samples were
enterovirus-positive, including coxsackievirus A6 (80%), coxsackievirus A16 (6%), enterovirus 71 (1%), coxsackievirus A5
(1%) and 12 non-typable enterovirus (12%). Bullous fluid aspirated from 2 patients also grew coxsackievirus A6. Among
the patients infected with coxsackievirus A6, 54% (45/81) had bullae, compared to 25% (5/20) of those having non-
coxsackievirus A6 infections (P=0.02). Fourteen cases had myoclonic jerks and one boy was diagnosed with febrile
convulsions. None had complications or sequelae. Phylogenetic analysis showed the strains in Taiwan in 2010 shared
more commonality with strains from Finland in 2009 (GenBank: FJ870502-FJ870508), and were close to those
circulating in Japan in 2011 (GenBank: AB649286-AB649291).
Conclusions: Coxsackievirus A6 infections may cause atypical manifestations of HFMD, including vesicles or papules on
faces or bullae on trunks. These features could provide valuable information to distinguish this versatile enterovirus
infection from other virus-induced vesiculobullous diseases.
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Phylogenetic analysisBackground
In children with infectious diseases, cutaneous lesions
usually provide clues for early diagnoses [1,2]. Hand-
foot-mouth disease (HFMD), a common and potentially
fatal infectious disease in children, largely relies on clinical
manifestations for early diagnosis, includingmaculopapular
or vesicular rashes on soles, palms and buttocks, and oral
ulcers in the pharynx [3]. Enteroviruses, particularly* Correspondence: lychang@ntu.edu.tw
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reproduction in any medium, provided the orenterovirus 71 (EV71) and coxsackievirus A16 (CVA16),
are known to cause HFMD. Most oral-dermatological
phenotypes are self-limited; however, in certain patients,
EV 71 infection may lead to severe neurological complica-
tions, especially in young children [4]. For example, during
an outbreak in 1998 in Taiwan, EV71 caused 78 deaths out
of more than 129,000 patients who had presented with
HFMD or herpangina initially [5]. Since then, the Centers
for Disease Control in Taiwan (CDC-Taiwan) have been
closely monitoring the trends of enterovirus infections by
cooperating with the Sentinel Physicians Surveillance andLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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database is published weekly and provides information re-
garding the circulating trends of enteroviruses [6].
Since spring 2010, we have observed an unusual type of
skin lesion presenting on children in Taiwan, including
large vesicles or bullae over the limbs, trunks or buttocks
and papules on faces, accompanied by fevers, stomatitis,
and sore throats. Moreover, a few children developed
onychomadesis, desquamation and skin pigmentation over
the areas previously presenting with large vesicles or
bullae. These presentations shared several of the traits of
HFMD, including vesicular regions on limbs and oral
ulcers, yet with distinct vesiculobullous lesions from the
typical maculopapular rashes. Over the past decade, the
association between onychomadesis and enterovirus infec-
tion has been reported in coxsackievirus A5 (CVA5),































Figure 1 Monthly and age distribution of atypical HFMD. (A) This epidem
peaked in between July and October. (B) Most of the children in the small ra
children under 5 year of age and 10% were teens.However, whether the morphology and distribution of ves-
icles and accompanying symptoms varied among entero-
virus infections of different serotypes remained unknown.
Therefore, we aimed to evaluate the etiology of the atyp-
ical presentations of HFMD during the epidemic period.
Results
Demography
Out of the 156 children screened between March and
December 2010, 101 children were enrolled in the study.
Most of them were recruited in the summer (Figure 1).
Fifty-five children were excluded because of incomplete
demographic data or lack of adequate clinical samples.
All participants had unremarkable medical histories.
Eighty percent (81/101) of the cases were recruited from
outpatient clinics, and the rest (20/101) from the emer-
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ic of CVA6 started in early spring of 2010. The enrollment of patients
sh group were younger than 6 year-old. In the bullae group, 78% were
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household. The mean age of the participants was 3.3 ±
3.0 years (median: 2.5 years, range: 21 days-13.5 years).
Males outnumbered female by 1.8 to 1, especially in pa-
tients with large bullae (p=0.004).
Virology examinations
The yield rate of viral cultures was only 18% (18/101). Six
specimens were CVA16-positive and 1 was EV71-positive.
RT-PCR was performed for these 7 specimens and con-
firmed the same results of the viral cultures. Four were
positive for enterovirus with uncertain serotypes due to an
initial limitation of available antibodies, and were later
confirmed to be CVA6 by RT-PCR and VP1 sequencing.
Of the remaining seven samples, one was echovirus 9, five
were cytomegalovirus, and the last was herpes simplex
virus. Cytomegalovirus and herpes simplex virus were con-
sidered latent viruses and not related to atypical HFMD.
Throat swabs of all participants were shown to be
enterovirus-positive by RT-PCR and the subsequent VP1
sequencing revealed eighty-one (80%) to be the serotype
of CVA6, six (6%) of CVA16, one (1%) of EV71, one
(1%) of CVA5 and 12 (12%) of non-typable EV (NTEV),
which could not be further serotyped due to low viral
titers. Additional samples from bullous fluid were col-
lected from 2 patients, which were further detected with
RT-PCR and VP1 sequencing. Both were positive for
CVA6. The viral load was 1.5*105 copies/mL fromFigure 2 Dermatologic presentations of atypical HFMD. Erythema was
distributed on limbs, trunks or perioral areas. (Top, left) Bullae were formed
sensations. (Top, right) Atypical rashes of CVA6 spread on a 4 year-old child
the cornea or conjunctiva. (Bottom, left) Late presentation of atypical HFMD
a 12 year-old boy. Ten days earlier, he had marked blisters on his bilateral l
systemic symptoms. (Bottom, right) Onychomadesis occurred on the 2 weePatient 1 (12.5 years old, male) and 1.9*107 copies/mL
from Patient 2 (2.9 years old, male). The viral loads of
the throat samples, from these two children on the same
dates as the fluid sample being collected, were lower
than that of the bulla fluid (Patient 1: 1*103 copies/mL;
Patient 2: 5*105 copies/mL).
Clinical presentations
Out of the 101 patients, the most common symptom
was fever (80%), followed by sore throats (59%), itchy
skin (32%), upper airway symptoms (27%), vomiting/
diarrhea (17%), and myalgia (2%). Neurological symp-
toms occurred in 15 children, including myoclonic jerks
(14%, 14/101) and febrile seizures (1%, 1/101). For the
dermatologic presentations, most of the children with
atypical HFMD presented lesions on their limbs (knee
and/or elbows, 98%), the typical sites of HFMD. Among
the atypical areas, lesions were most commonly distrib-
uted on faces (41%), along with buttocks (31%) and
trunks (29%). Vesiculobullous eruptions could also be
observed on thighs, on which rarely developed lesions in
typical HFMD. The patterns of the phenotype of atypical
HFMD are shown in Figure 2.
The analysis of clinical presentations between two
groups of skin lesions and between CVA6 and non-CVA6
infected patients are listed in Tables 1 and 2, respectively.
Children with large vesicles were more frequently CVA6-
positive (large vesicle group vs. small rash group: 90% vs.frequently observed at the base of large vesicles. These lesions were
on a 5 year-old boy’s sole, which caused mild pruritus and prickling
’s forehead and temporal area of the face. The lesions did not involve
, severe desquamation was presented on bilateral palms and soles of
imbs and scattered vesicles on his buttock, yet without fever or other
ks post CVA6 infection.
Table 1 Clinical presentations of two types of atypical HFMD
A typical HFMD (N=101) Large vesicles (N=50) Small rashes (N=51) P value*
Demographics
Age (year) 3.3 (± 3.8) 4.0 (± 3.7) 2.7 (± 1.8) 0.12
Male 65 (64%) 35 (70%) 30 (59%) 0.004
Female 36 (36%) 15 (30%) 21 (41%)
Etiology
CVA6 81 (80%) 45 (90%) 36 (70%) 0.01
Sites
Limbs 98 (97%) 49 (98%) 49 (96%) 1.00
Arm/Leg/Thigh 71 (70%) 35 (70%) 36 (70%) 1.00
Trunk 29 (29%) 21(42%) 8 (16%) 0.004
Buttocks 31 (31%) 17 (34%) 14 (27%) 0.52
Face 40 (41%) 22 (44%) 18 (35%) 0.42
Ear lobes 11 (11%) 6 (12%) 5 (10%) 0.76
Perioral area 26 (26%) 16 (32%) 10 (20%) 0.18
Symptoms
Fever 80 (80%) 40 (80%) 39 (76%) 0.81
Sore throat 59 (58%) 33 (66%) 26 (51%) 0.16
Cough/rhinorrhea 27 (27%) 14 (28%) 13 (25%) 0.83
Vomit/diarrhea 17 (17%) 6 (12%) 11 (22%) 0.29
Skin lesions
Itchiness 32 (32%) 22 (44%) 10 (20%) 0.01
Desquamation 1 (1%) 1 (2%) 0 (0%) 0.50
Pigmentation 6 (9%) 5 (10%) 1 (2%) 0.11
Prickle 2 (2%) 2 (4%) 0 (0%) 0.24
Myoclonic jerks 14 (14%) 5 (10%) 9 (18%) 0.39
Myalgia 2 (2%) 2 (4%) 0 (0%) 0.24
* P value represents the comparison of total numbers between male and female.
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commonly presented on trunks in the large vesicle group
(44% vs. 16% P=0.004). Also, children infected with CVA6
had higher chances of developing large vesicles than those
without (56% vs. 25%, P=0.02). Pruritus was the most
common complaint, and appeared more frequently in the
large vesicles group (44%) than in the small rashes group
(20%, P=0.01). The incidences of neurological symptoms
were similar between two skin lesion groups and between
two groups of CVA6 and non-CVA6 infections. None of
the patients had complications or sequelae.
Hospitalization
Seventeen cases (17%) were hospitalized. All were
discharged smoothly. Most hospitalized patients were
preschool children (mean age: 2.6 ± 2.9 years) and the
mean hospitalization duration was 3.2 ± 1.3 days. Dehy-
dration was the primary cause for hospitalization (76%).
Among 15 children presenting neurological symptoms,
only two patients required hospitalized evaluation. Onechild developed frequent myoclonic jerks and the other
had febrile convulsions. The hospitalization rate did not
differ between two skin-lesion groups, or between CVA6
and non-CVA6 groups.
Sequence analysis
Based on the sequences of the partial coding sequence of
the VP1 gene (GenBank: KC297130-KC297135), the con-
sensus sequences of our current study shared 93.1%-95.8%
nucleotide identity (100% amino acid identity) with the
2009 Finland strain (GenBank: FJ870502- FJ870508) and
were also close to those circulating in Japan in 2011
(GenBank: AB649286-AB649291) (Figure 3).
Discussion
Our data showed most of the CVA6 infections are a
common cause of atypical HFMD in children with rela-
tively benign courses. Among the lesions of atypical
HFMD, distinct bullae or large vesicles were more likely
to occur on CVA6-positive children. Also, children with
Table 2 Clinical presentations of patients acquiring CVA6 and non-CVA6 enterovirus infection
CVA6 positive (N=81) Non-CVA6* (N=20) P value
Demographics
Age (year) 3.5 (±3.2) 2.8 (±1.5) 0.92
Male 54 (67%) 11 (55%) 0.33
Female 27 (33%) 9 (45%)
Sites
Limbs 80 (99%) 18 (90%) 0.10
Arm/Leg/Thigh 56 (69%) 16 (80%) 0.79
Trunk 22 (27%) 7 (35%) 0.58
Buttocks 25 (30%) 6 (30%) 1.00
Face 34 (41%) 8 (40%) 0.80
Ear lobes 11 (13%) 0 0.12
Perioral area 23 (28%) 4 (20%) 0.27
Morphology
Large vesicles 45 (56%) 5 (25%) 0.02
Symptoms
Fever 66 (80%) 15 (75%) 0.37
Sore throat 49 (60%) 10 (50%) 0.45
Cough/rhinorrhea 23 (28%) 7 (35%) 0.58
Vomit/diarrhea 11 (13%) 6 (30%) 0.10
Skin lesions
Itchiness 27 (33%) 5 (25%) 0.60
Pigmentation 6 (7%) 3 (15%) 0.34
Prickle 2 (2%) 0 (0%) 1.00
Myoclonic jerks 11 (13%) 3 (15%) 1.00
Hospitalization
Days (days) 3.4 (± 1.3) 2.3 (± 0.6) 0.24
Age (years) 2.3 (± 3.1) 2.3 (± 0.6) 0.30
CVA6 denotes coxsackievirus A6.
* including 6 of CVA16, 1 of EV71, 1 of CVA5 and 12 of non-typable enterovirus.
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vesicles.
Before the epidemic in 2010, CVA6 circulation had
been observed in 2007 and 2009 in Northern Taiwan. In
the study by Lo et al. [9], most children infected with
CVA6 were < 7 years of age. Although 2% of the
children (3/141) had meningitis or encephalitis, none
had sequelae. The frequencies of myoclonic jerks
(21.3%) and febrile convulsions (3.5%) reported in Lo et
al’s study were similar to ours. However, less than 13%
of children presented with HFMD. Herpangina was the
predominant phenotype, which might be accompanied
by fever, decreased oral intake and upper respiratory
symptoms (e.g. cough and rhinorrhea). The epidemic
CVA6 strain in the current study in 2010 shared a great
deal of genetic commonality with the CVA6 strain in
2009 in Taiwan as determined by VP1 sequencing. Chen
et al. sequenced complete genomes of circulating CVA6strains between 2009 and 2010 in Taiwan, and revealed
little difference in VP1 sequences. However, several
changes in amino acids were noted in structure proteins
(VP2 and VP3) and non-structure proteins (2A, 3C and
3D) [10]. Whether the variations in amino acids contrib-
ute to the discerning clinical presentations in 2010 still
needs further investigation.
In our study, CVA6 was the major strain of entero-
virus that caused atypical HFMD. In the same epidemic
period, CDC-Taiwan retrospectively analyzed 130 pa-
tients with laboratory-confirmed CVA6 infections. Their
findings showed that CVA6 patients had higher chances
of experiencing desquamation (51%) and onychomadesis
(37%) [11]. This study did not analyze early presenta-
tions of the infection as in ours. Thus, the two studies
are in some part complementary, showing that in CVA6
infection, vesiculobullous lesions might develop early,
followed by marked desquamation and pigmentation on
Figure 3 The analysis of phylogeny is based on partial VP1 gene sequence (264–377 nucleotides). Clade I, is CVA6 strain HN421
(JQ964234), isolated from Henan, China in 2012. Clade II are the two circulating strains of CVA6 in Taiwan between 2004 and 2005 (EU908166,
EU908170). Clade III includes the prototype CVA6 strain from the USA (AY421764), Japanese circulating strains in 2011 (AB649286- AB649291),
2009 Finland strains (FJ870502- FJ870508) and Taiwanese circulating strains in 2009–2010 (JN896786, JN896796, JQ390220, JQ390221) and the
strains of the current study in 2010 (KC297130-KC297135).
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could also be observed after the resolution of infection.
These uncommon manifestations may provide valuable
information to detect enterovirus infections in endemic
countries. Early diagnosis is beneficial to pediatric pa-
tients in order to limit invasive examinations, such as
skin biopsies, when determining the pathogenesis.
We examined the bullous fluid collected from the skin
lesions. The viral loads of CVA6 were higher in the
bullous fluid than in the throat swabs. Similar observa-
tions have not been reported among the other HFMD
patients. Vesicular or bullous fluid may be considered a
specimen for a more sensitive but also more specific
source to determine the infectious etiology of HFMD,
since issues may be raised that bystander viruses and
true pathogens are indistinguishable in samples from
throats and feces. In murine models, viral titers of EV71
were much higher in muscle and skin compared to those
in the intestines or brain [12], suggesting enteroviruses
also propagate in other organs. It once again addresses
the importance of hand hygiene in the prevention of
HFMD. The transmission of enterovirus is not limited tothe oral-fecal route. Rather, it may pass on to other hosts
through fluid from ruptured skin lesions.
In the summer of 2008, a CVA6 outbreak was reported
in Finland and Spain, and the circulating strains in these
two countries shared high levels of similarity based on
partial VP1 sequences [7,8]. In the following years, out-
breaks of vesicular-bullous eruptions and onychomadesis
occurred in Taiwan (2010), Japan (2011) and the United
States (2012), and CVA6 was the viral stain responsible
for the events [11,13-15]. According to these reports and
ours, the majority of the infected patients had uncompli-
cated symptoms. The clinical presentations of CVA6
infections were quite different from those of EV71-
infected children, who usually presented small papules
or vesicles on distal limbs. Also, young children with
EV71 infections had much higher chances of developing
severe neurological complications, sequalae or mortal-
ities [16]. Moreover, CVA6 has become one of the en-
demic strains of enterovirus in Singapore, China and
Thailand in recent years [17-19]. It is not known
whether CVA6 may transform into a more virulent stain
as it circulates in broader regions. Further research is
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ical HFMD and in monitoring CVA6 epidemiology.
Several limitations of this study are summarized: (1) chil-
dren with maculopapular rashes over the uncommon sites
in addition to the bullous vesicles might be considered as
having viral exanthems, leading to underrepresentation
among the small rashes group. (2) Children who developed
skin lesions in the later phase of infection might be under-
represented if they were not hospitalized, or if they were
discharged early. (3) The number of patients was relatively
small due to the short epidemic period. More investigations
with expanded cohort sizes are required to explore the rela-
tionship between skin phenotypes and enterovirus species,
to provide evidence in clinical diagnosis.
Conclusion
xCoxsackievirus A6 infections may cause atypical pres-
entation of HFMD, including small vesicles on faces or
vesiculobullous lesions on trunks. The majority of pa-
tients were self-limited. The pathogenesis of CVA6-
induced bullae should be further investigated.
Patients and methods
Definition of atypical HFMD
The definition of atypical HFMD includes symptoms of
acute viral infection (such as fevers, coughs or diarrhea)
with either of the following presentations: (1) maculo-
papular rashes presenting on the trunks, buttocks or fa-
cial areas, or (2) large vesicles or bullae on any sites of
the body. Patients were classified into two groups
according to vesicle sizes by two pediatricians at differ-
ent points in time. The large vesicle group was defined
as having vesciculobullous lesions ≥ 1 cm in diameter;
the small rashes group had maculopapular rashes < 1cm
in diameter. We compared the clinical symptoms be-
tween the two groups.
Inclusion/exclusion criteria
National Taiwan University Hospital is a tertiary medical
center in Taipei, Taiwan, with 266 beds in pediatric de-
partments. Children with atypical HFMD were enrolled
prospectively through the outpatient clinics and the
emergency department between March and December
2010. Children who met the following conditions were
enrolled: (1) Under 18 years old, and (2) skin lesions
compatible with atypical HFMD. The early presentations
of atypical HFMD show two distinct characteristics:
(1) bullous lesions on limbs (i.e. elbows and knees),
buttocks and trunks, and (2) maculopapular rashes on
trunks, earlobes, and facial areas (i.e. periocular region).
Compared to these features, children with typical HFMD
commonly develop small vesicles (<0.5cm in diameter)
or macular rashes on the knees, elbows, palms and soles.
Written informed consent was obtained from each ofthe subject’s parents or guardians, and additional informed
consent was obtained from the subject himself or herself
if the subject was older than 8 years old. Pictures of spe-
cific skin lesions were taken also with consent.
Patients who met any of the following condition were
excluded: (1) Failure to obtain complete demographic
data, consent, or adequate clinical samples, (2) skin le-
sions were the results of diseases other than atypical
HFMD (such as drug hypersensitivity, Kawasaki disease,
or varicella infections), as determined after evaluation by
related specialists, and (3) having a history of systemic
illness, which might lead to an immunocompromised
state (e.g. patient received chemotherapy or immuno-
suppressive medications).
Information regarding the demographic data, medical
history and contact history were obtained from the pa-
tients or their caregivers. For hospitalized patients, our
clinical observation continued in the outpatient clinic
until one week after discharge, to determine any seque-
lae development. Two throat swabs were collected at the
time of diagnosis, one for viral isolation and the other
for polymerase chain reactions (PCR), to determine the
etiology. Clinical symptoms and signs were recorded on
the day of enrollment.
Viral isolation
Six types of cell lines were prepared for throat swab inocu-
lation, including human embryonic lung cells (HEL), hu-
man larynx carcinoma cells (HEp-2), rhabdomyosarcoma
cells (RD), monkey kidney cells (MK-2), and Madine-
Darby canine kidney cells (MDCK). After inoculating
throat swabs into the cells above, daily observation of the
cytopathic effect (CPE) was continued for 4 weeks. An
immunofluorescence study (Chemicon International Inc.,
Temecula, CA) was performed once CPE occurred, to de-
termine the pathogen.
Polymerase chain reaction (PCR)
(a) viral RNA extraction
Throat swabs were prepared for viral RNA extraction,
by using a MagNA Pure LC Total Nucleic Acid Isolation
kit (RNA and DNA extraction kit, Roche).
(b) reverse transcription polymerase chain reaction (RT-PCR)
Reverse transcription was performed with a First Strand
cDNA Synthesis Kit for RT-PCR (Invitrogen, CA, USA).
Previously extracted viral RNA was mixed with dNTP
and random hexamers. We performed real-time PCR for
pan-enterovirus with primers and probes based on the
highly conserved region in the 5’-untranslated region of
the enterovirus genome. The sequences of primers and
probes are listed as follows: forward primer, 5’-TCCTCC
GGCCCCTGAATG-3’; reverse primer, 5’-AATTGTCAC
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AACCGACTACTTTGGGTGTCCGTGTTTCXT-PH.
The mixture was incubated for the reaction at 65°C for
5 minutes. We subsequently added reagents into the mix-
ture, which included buffers, MgCl2, dithiothreitol (DTT),
RNase inhibitors and reverse transcriptase. Subsequently,
the samples were incubated at 25°C for 10 minutes
followed by 50°C for 50 minutes, 85°C for 5 minutes, and
4°C for 5 minutes.
(c) molecular typing of the circulating enterovirus during
the surveillance
A molecular typing of enterovirus was performed, once the
samples showed positive results for enterovirus in real time
RT-PCR or cytopathic effects. Three types of genogroup-
specific generate oligonucleotide primers flanking the VP1
region were designed, including EntAF TNCARGCWG
CNGARACNGG, EntAR outer ANGGRTTNGTNGMW
GTYTGCCA, EntAR inner GGNGGNACRWACATRTA
YTG; EntBF GCNGYNGARACNGGNCACAC, EntBR
outer CTNGGRTTNGTNGANGWYTGCC, EntBR inner
CCNCCNGGBGGNAYRTACAT; EntCF TNACNGCNG
TNGANACHGG, EntCR onter TGCCANGTRTANTCRT
CCC, EntCR inner GCNCCWGGDGGNAYRTACAT. The
PCR product was purified using the Gel/PCR DNA
fragments extraction kit (Geneaid, Taiwan) before se-
quencing. Auto-sequencing with the forward primer
was performed on an ABI 3730XL automatic sequencer
(AppliedBiosystems, CA, USA). The serotypes of the
enterovirus were determined by comparing partial VP1
sequences to the sequences in the public gene database
at the National Center for Biotechnology Information.
Phylogenetic analysis
To investigate the lineage of the circulating strains, we
performed phylogenetic analysis for the partial sequence
of the VP1 gene of present species and several previous
CVA6 strains. The comparison of sequences was based
on the partial VP1 sequences of CVA6. We selected the
strains of CVA6 isolated from different countries
between 2004 and 2012 to construct a phylogenetic tree:
a) Taiwan, GenBank: EU908166 (2004), EU908170 (2005),
JN896786 (2009), JN896796 (2009), JQ390220-JQ390221
(2010), KC297130-KC297135 (2010, strains from the
current study); b) USA, AY421764 (2004); c) Finland,
FJ870502- FJ870508 (2009); d) Japan, AB649286-AB649291
(2011); and e) China, JQ964234 (2012). We used Geneious
6.0.4 (Biomatters Ltd., New Zealand) to analyze the se-
quence and complete the diagram of phylogenetic analysis.
Statistics
We used SPSS Ver. 19 (IBM, USA) to analyze the clinical
data. Descriptive statistics were expressed as mean ± stan-
dard deviation (SD) for continuous variables. The medianvalue was used instead when continuous variables were not
normally distributed. A Student’s t-test was used to com-
pare the continuous variables with normal distributions in
two independent groups; a Mann–Whitney U test was for
continuous variables without normal distributions. A Chi
square test was performed to compare categorical vari-
ables. P-values less than 0.05 were considered statistically
significant.
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